Antigen and adjuvant components of an adjuvanted influenza vaccine are not mixed during manufacture, but are provided as separate components for extemporaneous mixing at the time of use, for example as a kit comprising: (i) an antigen component, comprising an influenza virus antigen and (ii) an adjuvant component, comprising an aluminium salt.
